Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,851
Closed -$606K 293
2025
Q4
$606K Buy
1,851
+600
+48% +$190K 0.04% 243
2025
Q3
$353K Buy
1,251
+353
+39% +$102K 0.02% 275
2025
Q2
$251K Buy
+898
New +$254K 0.02% 282
2021
Q4
Sell
-1,858
Closed -$395K 223
2021
Q3
$395K Hold
1,858
0.06% 205
2021
Q2
$453K Hold
1,858
0.07% 195
2021
Q1
$462K Buy
1,858
+186
+11% +$44.4K 0.08% 185
2020
Q4
$384K Hold
1,672
0.09% 169
2020
Q3
$425K Hold
1,672
0.13% 140
2020
Q2
$394K Hold
1,672
0.13% 111
2020
Q1
$339K Hold
1,672
0.14% 107
2019
Q4
$403K Sell
1,672
-374
-18% -$82.4K 0.13% 111
2019
Q3
$396K Buy
+2,046
New +$393K 0.13% 116

Other funds holding AMGN

IQ EQ Fund Management's AMGN Position: Q1 2026 in Review

IQ EQ Fund Management sold out of Amgen (AMGN) in Q1 2026, closing a stake of 1,851 shares — an estimated $606K sold.

IQ EQ Fund Management first reported a position in AMGN in Q3 2019 and held it in 12 quarters. The position peaked at $606K in Q4 2025. 3,128 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • IQ EQ Fund Management reported no remaining Amgen position as of Q1 2026 after selling out during the quarter.
  • IQ EQ Fund Management sold 1,851 Amgen shares in Q1 2026, an estimated $606K.
  • IQ EQ Fund Management first reported a position in Amgen in Q3 2019 and held it in 12 quarters.
  • IQ EQ Fund Management's Amgen position peaked at $606K in Q4 2025.
  • 3,128 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on IQ EQ Fund Management's 13F filing for Q1 2026, filed 11 May 2026.